Complexity reduction of clinical samples for routine mass spectrometric analysis
暂无分享,去创建一个
[1] B. Domon,et al. Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer* , 2012, Molecular & Cellular Proteomics.
[2] Adele Bourmaud,et al. Technical considerations for large-scale parallel reaction monitoring analysis. , 2014, Journal of proteomics.
[3] S. Carr,et al. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.
[4] F. Regnier,et al. Strategy for qualitative and quantitative analysis in proteomics based on signature peptides. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[5] R. Lewensohn,et al. Affinity prefractionation for MS‐based plasma proteomics , 2009, Proteomics.
[6] B. Domon,et al. Detection and quantification of proteins in clinical samples using high resolution mass spectrometry. , 2015, Methods.
[7] Philip S. Green,et al. On-line capillary column immobilised metal affinity chromatography/electrospray ionisation mass spectrometry for the selective analysis of histidine-containing peptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] D. Fenyö,et al. Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs , 2007, Nature Biotechnology.
[9] D. Suckau,et al. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow. , 2015, Methods.
[10] D R Mani,et al. Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma* , 2011, Molecular & Cellular Proteomics.
[11] B. Domon,et al. Mass spectrometry–based detection and quantification of plasma glycoproteins using selective reaction monitoring , 2012, Nature Protocols.
[12] Ruedi Aebersold,et al. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.
[13] B. Domon,et al. Improvement of the performance of targeted LC-MS assays through enrichment of histidine-containing peptides. , 2014, Journal of proteome research.
[14] F. Regnier,et al. Histidine-rich peptide selection and quantification in targeted proteomics. , 2004, Journal of proteome research.
[15] Darryl B. Hardie,et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.
[16] Susan E Abbatiello,et al. Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[17] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[18] N. Anderson,et al. The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.
[19] R. Aebersold,et al. Perspectives of targeted mass spectrometry for protein biomarker verification. , 2009, Current opinion in chemical biology.
[20] J. Yates,et al. Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.
[21] Pierre Thibault,et al. Improvement in peptide detection for proteomics analyses using NanoLC-MS and high-field asymmetry waveform ion mobility mass spectrometry. , 2005, Analytical chemistry.
[22] Ruedi Aebersold,et al. N-Glycoprotein SRMAtlas , 2013, Molecular & Cellular Proteomics.
[23] Glycosylation as means of reducing sample complexity to enable quantitative proteomics , 2009, Proteomics.
[24] Pengyuan Yang,et al. Large scale depletion of the high‐abundance proteins and analysis of middle‐ and low‐abundance proteins in human liver proteome by multidimensional liquid chromatography , 2008, Proteomics.
[25] B. Domon,et al. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach. , 2015, Journal of proteome research.
[26] Ruedi Aebersold,et al. On the development of plasma protein biomarkers. , 2011, Journal of proteome research.
[27] Bruno Domon,et al. Considerations on selected reaction monitoring experiments: Implications for the selectivity and accuracy of measurements , 2012, Proteomics. Clinical applications.
[28] F. Regnier,et al. Proteomics based on selecting and quantifying cysteine containing peptides by covalent chromatography. , 2001, Journal of chromatography. A.
[29] Bruno Domon,et al. Targeted proteomics strategy applied to biomarker evaluation , 2013, Proteomics. Clinical applications.
[30] Susan E Abbatiello,et al. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. , 2010, Clinical chemistry.
[31] J. Rossier,et al. Two‐stage Off‐Gel™ isoelectric focusing: Protein followed by peptide fractionation and application to proteome analysis of human plasma , 2005, Electrophoresis.
[32] Bruno Domon,et al. Selectivity of LC-MS/MS analysis: implication for proteomics experiments. , 2013, Journal of proteomics.
[33] P. Davidsson,et al. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples , 2005, Proteomics.
[34] V. Marx. Targeted proteomics , 2013, Nature Methods.
[35] R. Aebersold,et al. A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.
[36] Ruedi Aebersold,et al. Chemical probes and tandem mass spectrometry: a strategy for the quantitative analysis of proteomes and subproteomes. , 2004, Current opinion in chemical biology.
[37] Yu‐Ju Chen,et al. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry. , 2015, Journal of proteome research.
[38] B. Domon,et al. Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC‐MS in PRM mode , 2015, Proteomics. Clinical applications.
[39] N. Ahn,et al. Quantifying the impact of chimera MS/MS spectra on peptide identification in large-scale proteomics studies. , 2010, Journal of proteome research.
[40] W. Hancock,et al. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. , 2004, Journal of chromatography. A.
[41] Yuan Tian,et al. Solid-phase extraction of N-linked glycopeptides , 2007, Nature Protocols.
[42] B. Domon,et al. Selected reaction monitoring applied to proteomics. , 2011, Journal of mass spectrometry : JMS.
[43] Juan Astorga-Wells,et al. Rapid and Deep Human Proteome Analysis by Single-dimension Shotgun Proteomics* , 2013, Molecular & Cellular Proteomics.
[44] B. Ueberheide,et al. Detection and correction of interference in SRM analysis. , 2013, Methods.
[45] N Leigh Anderson,et al. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.
[46] J. Hirabayashi,et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins , 2003, Nature Biotechnology.
[47] N. Anderson,et al. Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.
[48] Jens M. Rick,et al. Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.
[49] Derek J. Bailey,et al. Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.
[50] G. Nicol,et al. Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients* , 2008, Molecular & Cellular Proteomics.
[51] Jeffrey R. Whiteaker,et al. Head-to-head comparison of serum fractionation techniques. , 2007, Journal of proteome research.
[52] K. Gruber,et al. Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. , 2001, Analytical chemistry.
[53] Fuchu He,et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. , 2006, Journal of proteome research.